Which cytokines are commonly elevated in periodontal inflammation and drive tissue destruction?

Which cytokines are commonly elevated in periodontal inflammation and drive tissue destruction?

• A. IL-1β, IL-6, TNF-α, and IL-17
• B. IL-4, IL-10, TGF-β, and IL-2
• C. IL-8, IL-13, IL-15, and IL-18
• D. IFN-γ, IL-12, IL-23, and GM-CSF

Answer: (A)

In periodontal inflammation, tissue destruction is driven by pro-inflammatory cytokines released in response to bacterial biofilm. The four cytokines IL-1β, IL-6, TNF-α, and IL-17 are central players because they promote both connective tissue breakdown and bone loss. IL-1β and TNF-α upregulate matrix metalloproteinases and prostaglandins, and they boost RANKL expression to activate osteoclasts. IL-6 supports inflammation and enhances osteoclastogenesis, partly by promoting Th17 responses. IL-17, produced by Th17 cells, amplifies neutrophil recruitment and further stimulates RANKL, accelerating osteoclast formation and matrix degradation. Together, these mediators create a destructive inflammatory milieu in the periodontium. Other options involve anti-inflammatory or regulatory cytokines (like IL-4, IL-10, TGF-β, IL-2) or mediators more focused on chemotaxis (IL-8) or Th1-type responses (IFN-γ, IL-12, IL-23, GM-CSF) that are not the primary drivers of tissue destruction in periodontitis.

In periodontal inflammation, tissue destruction is driven by pro-inflammatory cytokines released in response to bacterial biofilm. The four cytokines IL-1β, IL-6, TNF-α, and IL-17 are central players because they promote both connective tissue breakdown and bone loss. IL-1β and TNF-α upregulate matrix metalloproteinases and prostaglandins, and they boost RANKL expression to activate osteoclasts. IL-6 supports inflammation and enhances osteoclastogenesis, partly by promoting Th17 responses. IL-17, produced by Th17 cells, amplifies neutrophil recruitment and further stimulates RANKL, accelerating osteoclast formation and matrix degradation. Together, these mediators create a destructive inflammatory milieu in the periodontium.

Other options involve anti-inflammatory or regulatory cytokines (like IL-4, IL-10, TGF-β, IL-2) or mediators more focused on chemotaxis (IL-8) or Th1-type responses (IFN-γ, IL-12, IL-23, GM-CSF) that are not the primary drivers of tissue destruction in periodontitis.